“SLC39A1 Contributes to Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma by Activating AMPK Signaling”. 2024. Bangladesh Journal of Pharmacology 19 (2): 52-58. https://doi.org/10.3329/bjp.v19i2.72787.